We can't find the internet
Attempting to reconnect
26118.2 PFLS-LS
A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies
Résumé
A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies
Textes supplémentaires
Abstract
Capitalizing on programmable cell fate regulation, we present a high-content screening platform measuring the differentiation capacity of pluripotent stem cells in a rapid, non-disruptive and inexpensive manner, enabling identification of high-quality stem cells for commercial applications.
Participants
Martin Fussenegger
Kontaktperson
fussenegger@bsse.ethz.ch
ETH Zürich department of biosystems science an D-BSSE Martin Fussenegger Mattenstrasse 26 4058 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2018-02-28
- Date de fin
- 2019-08-31
- Coûts totaux approuvés
- CHF 336936.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%